InMed Pharmaceuticals Inc. (INM)
Market Closed
12 Dec, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
1. 45
+0.06
+4.32%
$
2.39M Market Cap
- P/E Ratio
0% Div Yield
302,781 Volume
0 Eps
$ 1.39
Previous Close Day Range
1.35 1.48
Year Range
1.13 8.27
Want to track INM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 58 days
InMed Pharmaceuticals Advances Oral Candidate For Alzheimer's Disease, Stock Surges On Tuesday
On Tuesday, InMed Pharmaceuticals Inc. INM confirmed INM-901 as an oral formulation that will be utilized in its development programs for Alzheimer's disease.
Benzinga | 1 year ago
2025 © Marketlog. All Rights Reserved.
